文献速递肿瘤 PET/CT核素与放射性配体治疗

接受PSMA治疗的的前列腺癌患者经PSMA-PET/CT评估身体组成的预后价值

Prognostic value of body composition out of PSMA-PET/CT in prostate cancer patients undergoing PSMA-therapy.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2025-06-28

本回顾性研究利用深度学习模型从86例转移性去势抵抗性前列腺癌(mCRPC)患者接受[177Lu]Lu-PSMA放射性配体治疗前的[68Ga]Ga-PSMA-PET/CT中自动分割腹部内脏脂肪、皮下脂肪及肌间脂肪,比较3D与2D单层脂肪组织比例对预后的价值。Cox回归显示3D模型中较低皮下脂肪比与较高肌间脂肪比与更差治疗结局相关,肌间脂肪比在多因素分析中为独立生存预测因子。

要点

  • 深度学习模型可自动分割不同脂肪组织隔室及骨骼肌。
  • 3D模型中SAT/TAT较低(p=0.038)与IMAT/TAT较高(p<0.001)与更差结局相关。
  • IMAT比例在多因素分析中为独立生存预测因子。

核心结论

  • 在这项原理验证研究中,基于深度学习的全身分析可为接受放射性配体治疗的mCRPC患者提供稳健且详细的基于CT的身体组成评估。
  • 潜在的预后参数需在更大的前瞻性数据集中加以证实。

研究设计与样本

  • 回顾性研究,纳入86例接受放射性配体治疗前的转移性去势抵抗性前列腺癌患者,使用深度学习分割模型对[68Ga]Ga-PSMA-PET-CT进行全自动组织隔室分割。
  • 比较基于腹部3D CT体积与基于第三腰椎(L3)中心的2D单层切片所评估的各脂肪组织隔室占全部脂肪组织比例对预后的价值。
  • 先进行单因素和多因素Cox比例风险回归分析,随后按组织中位数二分,用Kaplan-Meier分析和log-rank检验评估亚组。

主要发现

  • 自动分割模型可用于描绘不同患者解剖结构中的不同脂肪组织隔室和骨骼肌。
  • Cox回归分析显示,3D模型中较低的SAT/TAT与较高的IMAT/TAT与更差治疗结局显著相关(SAT/TAT:p=0.038;IMAT/TAT:p<0.001)。
  • 在单层切片方法中,仅IMAT/SAT与生存显著相关(p<0.001;SAT/TAT:p>0.05)。
  • 多因素分析中纳入PSMA-PET和血液学预后因素时,IMAT比例仍为独立的生存预测因子。

局限性

  • 原文为回顾性研究。
  • 原文为原理验证研究,结论指出潜在预后参数需在更大的前瞻性数据集中加以证实。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: This retrospective study aims to develop a deep learning-based approach to whole-body CT segmentation out of standard PSMA-PET-CT to assess body composition in metastatic castration resistant prostate cancer (mCRPC) patients prior to [177Lu]Lu-PSMA radioligand therapy (RLT). Our goal is to go beyond standard PSMA-PET-based pretherapeutic assessment and identify additional body composition metrics out of the CT-component, with potential prognostic value. METHODS: We used a deep learning segmentation model to perform fully automated segmentation of different tissue compartments, including visceral- (VAT), subcutaneous- (SAT), intra/intermuscular- adipose tissue (IMAT) from [68 Ga]Ga-PSMA-PET-CT scans of n = 86 prostate cancer patients before RLT. The proportions of different adipose tissue compartments to total adipose tissue (TAT) assessed on a 3D CT-volume of the abdomen or on a 2D single slice basis (centered at third lumbal vertebra (L3)) were compared for their prognostic value. First, univariate and multivariate Cox proportional hazards regression analyses were performed. Subsequently, the subjects were dichotomized at the median tissue composition, and these subgroups were evaluated by Kaplan-Meier analysis with the log-rank test. RESULTS: The automated segmentation model was useful for delineating different adipose tissue compartments and skeletal muscle across different patient anatomies. Analyses revealed significant correlations between lower SAT and higher IMAT ratios and poorer therapeutic outcomes in Cox regression analysis (SAT/TAT: p = 0.038; IMAT/TAT: p < 0.001) in the 3D model. In the single slice approach only IMAT/SAT was significantly associated with survival in Cox regression analysis (p < 0.001; SAT/TAT: p > 0.05). IMAT ratio remained an independent predictor of survival in multivariate analysis when including PSMA-PET and blood-based prognostic factors. CONCLUSIONS: In this proof-of-principle study the implementation of a deep learning-based whole-body analysis provides a robust and detailed CT-based assessment of body composition in mCRPC patients undergoing RLT. Potential prognostic parameters have to be corroborated in larger prospective datasets.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Roll W, Plagwitz L, Ventura D, et al. Prognostic value of body composition out of PSMA-PET/CT in prostate cancer patients undergoing PSMA-therapy. Eur J Nucl Med Mol Imaging. 2025. PMID: 40580320. doi:10.1007/s00259-025-07416-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。